(Q49117984)
Statements
Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1a (English)
S Wagenpfeil
P Freitag
E Fisher
R A Rudick
M Kooijmans
M Clanet
E W Radue
L Kappos
European IFN-1a in Relapsing MS Dose Comparison Trial Study Group